BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Silicon Valley Billionaires Invest $5B+ in Longevity Tech, Betting on AI and Biotech
Silicon Valley Billionaires Invest $5B+ in Longevity Tech, Betting on AI and Biotech
13
2
BTCCSquare news:
Silicon Valley's elite have poured over $5 billion into longevity research over the past quarter-century, viewing aging as a solvable engineering challenge. Peter Thiel, Sam Altman, and other tech luminaries are backing startups focused on AI-driven drug discovery, cell rejuvenation, and health monitoring technologies.
Investment rounds in the sector have grown 20% in the last decade, averaging $43 million per deal. Notable fundraises include Coinbase CEO Brian Armstrong's NewLimit ($130M) and Altos Labs' record $3 billion launch in 2022. The capital influx reflects growing confidence in biotechnology's potential to rewrite human biology.
By:
